IMP Pharmaceutical sets target to reach 2011 profit of 100b dong, up 2pct y-o-y

Imexpharm Pharmaceutical Joint Stock Co (coded IMP) has recently released the 2011 business plan with total revenue of 800 billion dong, increasing by 3 percent against the previous year, and pre-tax profit of 100 billion dong, up 2 percent year-on-year.



Last year, IMP reported earning total revenue of 777 billion dong and pre-tax profit of 98 billion dong. The company planned to pay dividend at 22 percent over chartered capital of 160 billion dong.



The company planned to spend 35.2 billion dong for paying dividend.

Tags: Vietnam business news, Vietnam companies

Posted by VBN on Mar 28 2011. Filed under Enterprises. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry